121 related articles for article (PubMed ID: 6139097)
1. Neuropharmacological profile of MD 790501, a new benzamide derivative.
Jalfre M; Bucher B; Dorme N; Mocquet G; Porsolt RD
Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):232-56. PubMed ID: 6139097
[TBL] [Abstract][Full Text] [Related]
2. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
Ogren SO; Hall H; Köhler C; Magnusson O; Florvall L
Arzneimittelforschung; 1985; 35(8):1227-31. PubMed ID: 2866774
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
Yamasaki T; Kojima H; Sakurai T; Kasahara A; Watanabe S; Fujiwara M; Ueki S
Arzneimittelforschung; 1981; 31(4):701-7. PubMed ID: 6113833
[No Abstract] [Full Text] [Related]
4. Benzamides and classical neuroleptics: comparison of their actions using 6 apomorphine-induced effects.
Puech AJ; Simon P; Boissier JR
Eur J Pharmacol; 1978 Aug; 50(4):291-300. PubMed ID: 29758
[TBL] [Abstract][Full Text] [Related]
5. Behavioral pharmacology of the benzamides as compared to standard neuroleptics.
Worms P
Adv Biochem Psychopharmacol; 1982; 35():7-16. PubMed ID: 6128876
[No Abstract] [Full Text] [Related]
6. Pharmacological study of [2-chloro-11-(2-dimethylaminoethoxy) dibenzo[b,f]thiepine] (zotepine), a new neuroleptic drug.
Uchida S; Honda F; Otsuka M; Satoh Y; Mori J; Ono T; Hitomi M
Arzneimittelforschung; 1979; 29(10):1588-94. PubMed ID: 42413
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
[No Abstract] [Full Text] [Related]
8. Pharmacological and biochemical studies on a new potential neuroleptic, N-(1-benzyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-08050).
Usuda S; Sano K; Maeno H
Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):68-78. PubMed ID: 43118
[TBL] [Abstract][Full Text] [Related]
9. Neuropharmacological profile of MD 780515, a new reversible inhibitor of type A monoamine oxidase.
Jalfre M; Bucher B; Coston A; Mocquet G; Porsolt RD
Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):194-221. PubMed ID: 6129835
[TBL] [Abstract][Full Text] [Related]
10. Amoxapine in experimental psychopharmacology: a neuroleptic or an antidepressant?
Chermat R; Simon P; Boissier JR
Arzneimittelforschung; 1979; 29(5):814-20. PubMed ID: 40575
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of picobenzide (3,5-dimethyl-N-(pyridin-4-ylmethyl)benzamide) analogues as potential antipsychotic agents.
Gradillas A; López B; Braña MF; Sancho I; Pérez-García C; Alguacil LF
Arzneimittelforschung; 2005; 55(12):725-9. PubMed ID: 16430025
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological studies of an antipschotic agent, penfluridol. (1). The central pharmacological actions].
Ito K; Nurimoto S; Shintomi K; Kowa Y; Yamamura M; Ishida R
Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):795-813. PubMed ID: 828132
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
[TBL] [Abstract][Full Text] [Related]
14. Clopimozide (R 29 764), a new highly potent and orally long-acting neuroleptic of the diphenylbutylpiperidine series.
Janssen PA; Niemegeers CJ; Schellekens KH; Lenaerts FM; Wauquier A
Arzneimittelforschung; 1975 Aug; 25(8):1287-94. PubMed ID: 1242360
[TBL] [Abstract][Full Text] [Related]
15. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
Christensen AV; Arnt J; Hyttel J; Svendsen O
Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
[TBL] [Abstract][Full Text] [Related]
16. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
[TBL] [Abstract][Full Text] [Related]
17. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Bartoszyk GD; Harting J; Minck KO
J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
[TBL] [Abstract][Full Text] [Related]
18. Is dopamine antagonism a requisite of neuroleptic activity?
Greenblatt EN; Coupet J; Rauh E; Szucs-Myers VA
Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):105-19. PubMed ID: 6111298
[TBL] [Abstract][Full Text] [Related]
19. [General pharmacologic studies on the analgesic flupirtine].
Jakovlev V; Achterrath-Tuckermann U; von Schlichtegroll A; Stroman F; Thiemer K
Arzneimittelforschung; 1985; 35(1):44-55. PubMed ID: 4039152
[TBL] [Abstract][Full Text] [Related]
20. Psychopharmacological profile of mesterolone.
Baran L; Przegaliński E
Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
